Development of quantitative systems pharmacology and toxicology models within consortia: experiences and lessons learned through DILIsym development
This article highlights lessons learned from past experiences associated with The DILI-sim Initiative – a collaborative effort focused on developing DILIsym software for predicting drug-induced liver injury (DILI).
Source: Drug Discovery Today: Disease Models - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Learning | Lessons | Liver | Toxicology | Universities & Medical Training | Urology & Nephrology